EARNEST Partners
CNMD icon

EARNEST Partners’s CONMED CNMD Stock Holding History

EARNEST Partners’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82M Sell
2,505,295
-64,358
-3% -$2.32M 0.3% 128
2026
Q1 		$90.9M Sell
2,569,653
-93,300
-4% -$3.8M 0.37% 105
2025
Q4 		$108M Sell
2,662,953
-135,750
-5% -$5.91M 0.46% 85
2025
Q3 		$132M Sell
2,798,703
-31,212
-1% -$1.62M 0.57% 61
2025
Q2 		$147M Buy
2,829,915
+30,216
+1% +$1.66M 0.66% 51
2025
Q1 		$169M Sell
2,799,699
-10,477
-0.4% -$675K 0.81% 33
2024
Q4 		$192M Buy
2,810,176
+25,876
+0.9% +$1.8M 0.86% 27
2024
Q3 		$200M Sell
2,784,300
-34,306
-1% -$2.42M 0.87% 29
2024
Q2 		$195M Buy
2,818,606
+447,498
+19% +$32.6M 0.91% 25
2024
Q1 		$190M Buy
2,371,108
+25,411
+1% +$2.26M 0.87% 29
2023
Q4 		$257M Buy
2,345,697
+80,605
+4% +$8.33M 1.28% 10
2023
Q3 		$228M Buy
2,265,092
+44,076
+2% +$5.06M 1.32% 7
2023
Q2 		$302M Sell
2,221,016
-494,873
-18% -$60.4M 1.69% 5
2023
Q1 		$282M Buy
2,715,889
+313,537
+13% +$30.3M 1.63% 5
2022
Q4 		$213M Buy
2,402,352
+335,974
+16% +$27.9M 1.31% 7
2022
Q3 		$166M Buy
2,066,378
+404,586
+24% +$38.2M 1.11% 16
2022
Q2 		$159M Buy
1,661,792
+187,134
+13% +$22.5M 1.06% 19
2022
Q1 		$219M Sell
1,474,658
-44,665
-3% -$6.24M 1.3% 13
2021
Q4 		$215M Sell
1,519,323
-83,807
-5% -$11.9M 1.24% 18
2021
Q3 		$210M Sell
1,603,130
-25,718
-2% -$3.36M 1.28% 12
2021
Q2 		$224M Sell
1,628,848
-7,824
-0.5% -$1.07M 1.32% 13
2021
Q1 		$214M Buy
1,636,672
+61,336
+4% +$7.38M 1.28% 17
2020
Q4 		$176M Buy
1,575,336
+459,191
+41% +$43.5M 1.22% 16
2020
Q3 		$87.8M Buy
+1,116,145
New +$91M 0.76% 51

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

EARNEST Partners's CNMD Position: Q2 2026 in Review

EARNEST Partners reduced its CONMED (CNMD) stake by 2.5% in Q2 2026, selling an estimated $2.32M and leaving 2,505,295 shares worth $82M. The position accounts for 0.3% of the portfolio, ranked #128.

EARNEST Partners first reported a position in CNMD in Q3 2020 and has held it in 24 quarters since. The position peaked at $302M in Q2 2023. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • EARNEST Partners held 2,505,295 shares of CONMED worth $82M as of Q2 2026.
  • EARNEST Partners sold 64,358 CONMED shares in Q2 2026, an estimated $2.32M.
  • CONMED made up 0.3% of EARNEST Partners's portfolio in Q2 2026, its #128 holding.
  • EARNEST Partners first reported a position in CONMED in Q3 2020 and has held it in 24 quarters since.
  • EARNEST Partners's CONMED position peaked at $302M in Q2 2023.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on EARNEST Partners's 13F filing for Q2 2026, filed 13 Aug 2026.